Gatehouse Bio is a TechBio company decoding small RNA (sRNA) isoforms to develop biomarker-guided precision oligonucleotide therapeutics. Using our AI-powered Code-Breaker™ Platform, we are expanding and characterizing the functional landscape of sRNAs, discovering disease-associated isoforms, and digitally designing therapeutics to counteract their effect.
